Skip to Content
Merck
  • Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial.

Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial.

JACC. Cardiovascular imaging (2017-04-17)
Michael T Lu, Maros Ferencik, Rhonda S Roberts, Kerry L Lee, Alexander Ivanov, Elizabeth Adami, Daniel B Mark, Farouc A Jaffer, Jonathon A Leipsic, Pamela S Douglas, Udo Hoffmann
ABSTRACT

The purpose of this study was to determine whether noninvasive fractional flow reserve derived from computed tomography (FFR FFR This observational cohort study included patients with stable chest pain in the PROMISE (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) trial referred to ICA within 90 days after CTA. FFR FFR In this hypothesis-generating study of patients with stable chest pain referred to ICA from CTA, an FFR

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethyl 2-(4-methoxyphenylcarbonothioylthio)acetate, 99%